Hippo Insider Discloses 5,177-Share Sale; 65,817 RSUs Remain

Rhea-AI Filing Summary

Hippo Holdings Inc. insider Guy Zeltser, the company's Chief Financial Officer, reported sales of common stock on 09/17/2025 executed under a Rule 10b5-1 trading plan dated June 18, 2025. The Form 4 shows two sale line items totaling 5,177 shares sold at weighted average prices of $37.4569 and $38.045, leaving the reporting person with 74,861 shares beneficially owned after the transactions.

The filing notes that the remaining holdings include 65,817 RSUs. The reporting person certified the sales and provided undertakings to supply trade-level details on request.

Positive

• Sales executed under a documented Rule 10b5-1 trading plan, indicating pre-arranged, compliant insider transactions
• Filer provides to supply detailed trade-level information on request, increasing transparency
• Form 4 is signed and dated, reflecting compliance with reporting requirements

Negative

• Reporting person reduced holdings by 5,177 shares, decreasing beneficial ownership to 74,861 shares
• Majority of remaining holdings are RSUs (65,817), indicating a large portion may be subject to vesting conditions rather than free-trading shares

Insights

Financial Analyst

TL;DR Insider sales via a pre-established 10b5-1 plan reduced the CFO's stake modestly; transaction appears routine, not an operational signal.

The CFO sold 5,177 shares under a Rule 10b5-1 plan at weighted average prices in the $36.95 to $38.11 range. Post-sale beneficial ownership is 74,861 shares including 65,817 RSUs. Because the trades were executed through a documented 10b5-1 plan and the filer offers to provide trade-level detail on request, this disclosure aligns with standard insider liquidity activity rather than an unscheduled market-moving event. Investors should note the continued large RSU component but the filing itself is informational and not indicative of company performance.

Corporate Governance Expert

TL;DR Filing demonstrates governance compliance: sales executed under a 10b5-1 plan and signed certification reduce compliance risk.

The Form 4 clearly states the Rule 10b5-1 plan date and provides weighted average pricing ranges, with an undertaking to disclose detailed trade information upon request. The reporting person signed the form, and the disclosure that 65,817 of the remaining shares are RSUs provides useful clarity on the composition of holdings. From a governance perspective, this is a compliant and transparent insider disclosure; the transactions themselves are routine insider liquidity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Zeltser Guy

(Last) (First) (Middle)

C/O HIPPO HOLDINGS INC., 1 ALMADEN BLVD

SUITE 400

(Street)

SAN JOSE CA 95113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hippo Holdings Inc. [ HIPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		S(1)		4,977	D	$37.4569(2)	75,061	D
Common Stock	09/17/2025		S(1)		200	D	$38.045(3)	74,861(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales were effected pursuant to a Rule 10b5-1 trading plan dated June 18, 2025.

2. This transaction was executed in multiple trades at prices ranging from $36.95 to $37.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $37.98 to $38.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. Includes 65,817 RSUs.

Remarks:

	Guy Zeltser	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Hippo Holdings (HIPO) disclose in this Form 4?

The CFO, Guy Zeltser, sold a total of 5,177 common shares on 09/17/2025 under a Rule 10b5-1 plan, leaving him with 74,861 shares beneficially owned.

Were the sales by the Hippo CFO pre-planned or discretionary?

The sales were executed pursuant to a Rule 10b5-1 trading plan dated June 18, 2025, indicating they were pre-planned.

At what prices were the Hippo shares sold according to the Form 4?

The filing reports weighted average prices of $37.4569 and $38.045; the filing explains trades occurred in multiple executions within specified price ranges.

How many of the remaining shares are restricted stock units (RSUs)?

The Form 4 states that the remaining holdings include 65,817 RSUs.

Does the filing offer additional details about the individual trades?

Yes. The reporting person undertakes to provide, upon request, full information regarding the number of shares and prices at which the transactions were effected.